Healing of chronic wounds by using Katphala Kshar- Plota and Nirgundi oil locally

Not yet recruiting

• Conditions: Local infection of the skin and subcutaneous tissue, unspecified. Ayurveda Condition: DUSHTAVRANAH,

• Registration Number: CTRI/2022/07/043745
• Lead Sponsor: Uttarakhand Ayurved University

Brief Summary

Healing of Vrana is a physiological process of regeneration and repair after injury. Due to interference of vitiated Doshas, Vrana becomes Dushta and normal healing gets delayed. Dushta -Vrana can be considered as Chronic Non-Healing ulcer like venous ulcer, diabetic ulcer, arterial ulcer, infected ulcer. The presence of Dushta-Vrana worsens the condition of the patient to a greater extent. Dushta- Vrana being a chronic ailment causes long term suffering and which may even become fatal.Kshar is non-invasive procedure without major complications, does the Shodhana of Dushta Vrana, remove all slough/dead tissue and Vrana becomes Shuddha and thus enhances wound healing. Acharya Sushrutaalso defines the Kshara, the substance processing Ksharana (melting away) and Kshanana (destroying the lesion) properties. Acharya Sushruta has given number of Vrana-bandhan dravya viz., Pichu, Plota, Kawalika and Vikeshika. He advocated numerous herbal drugs for local application as well as systemic use. Katphala, Daruharidraand Nirgundi are the plants mentioned specially for Dushta-Vrana by Acharya Sushruta. So, Katphala Kshar-plota and Nirgundi Taila for Shodhana and Ropana of Dushta-Vrana by local application is a good alternative.

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2022-02-07
• Study Start: 2022-09-07

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 34

Inclusion Criteria

• Patient suffering from Dushta-Vrana on any part of the body.
• All age groups patients.
• Non specific ulcers.
• Post operative infected wounds.

Exclusion Criteria

• Patient with evidence of malignancy and malignant ulcers.
• Tubercular ulcers.
• Syphilitic ulcers.
• Underlying bony lesions.
• Patient with bleeding disorders.
• HIV,Hepatitis B, Hepatitis C positive patient.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Healing in Chronic Wounds will be assessed based on following parameters -	It be assessed every 15th Day for 6 months
1. Improvement in Tenderness	It be assessed every 15th Day for 6 months
2. Reduction in Foul Smell	It be assessed every 15th Day for 6 months
3. Floor/Granulation	It be assessed every 15th Day for 6 months
4. Reduction in Size	It be assessed every 15th Day for 6 months
5. Decrease in amount of Discharge	It be assessed every 15th Day for 6 months
6. Relief in Intensity of Itching	It be assessed every 15th Day for 6 months
7. Decrease in intensity of Pain	It be assessed every 15th Day for 6 months

Secondary Outcome Measures

Name	Time	Method
Healing of wound	It be assessed every 15th Day for 6 months

Trial Locations

Locations (1)

Rishikul Campus, Haridwar; 🇮🇳 Hardwar, UTTARANCHAL, India

Rishikul Campus, Haridwar

🇮🇳Hardwar, UTTARANCHAL, India

Dr Suman kohali

Principal investigator

8126337618

Sumankantikohali26@gmail.com